Picture of Healius logo

HLS — Healius News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Healius Expects Underlying FY 2024 EBITDA Of A$359 Million - A$369 Million

Feb 21 (Reuters) - Healius Ltd  HLS.AX :
    * NOW EXPECTS UNDERLYING FY 2024 EBITDA OF A$359 MILLION -
A$369
MILLION
    * VOLUME GROWTH SEEN IN Q1 OF FY 2024 HAS SOFTENED
    * EXPECTS UNDERLYING EBITDA OF A$158 MILLION - A$161 MILLION
FOR
HY
    * NON-CASH IMPAIRMENT CHARGE OF A$603 MILLION WILL BE MADE
TO
GOODWILL IN PATHOLOGY DIVISION IN 1H 2024 RESULTS
    * RESPONDING TO SOFTENED VOLUME GROWTH WITH ACCELERATED PLAN
TO
RESHAPE BUSINESS AND MATCH COSTS TO CURRENT VOLUMES

Source text for Eikon:  ID:nASX9D28y0 
Further company coverage:  HLS.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Healius

See all news